Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers

Yang Wu; Zili Zhang

doi:10.3389/fendo.2024.1533623

Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers

Front Endocrinol (Lausanne). 2024 Dec 11:15:1533623. doi: 10.3389/fendo.2024.1533623. eCollection 2024.

Authors

Yang Wu^{1

2}, Zili Zhang¹

Affiliations

¹ School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
² Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

No abstract available

Keywords: biomarker; clinical applications; endocrine-related cancers; molecular mechanisms; targeted therapy.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The work was supported by the National Natural Science Foundation of China (No.82474164), the Natural Science Foundation of Jiangsu Province (No. BK20220467), Jiangsu Provincial Double-Innovation Doctor Program (No. JSSCBS20220452, JSSCBS20220472), Young Elite Scientists Sponsorship Program by CACM (No. 2022-QNRC2-B15), Outstanding Young Doctoral Training Program (No. 2023QB0124). The work was sponsored by Qing Lan Project.